.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
Moodys
US Army
Argus Health
Medtronic
Teva
Johnson and Johnson
Dow
Colorcon

Generated: December 17, 2017

DrugPatentWatch Database Preview

MAXZIDE-25 Drug Profile

« Back to Dashboard

Which patents cover Maxzide-25, and when can generic versions of Maxzide-25 launch?

Maxzide-25 is a drug marketed by Mylan Pharms Inc and is included in one NDA.

The generic ingredient in MAXZIDE-25 is hydrochlorothiazide; triamterene. There are thirty-one drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.
Drug patent expirations by year for MAXZIDE-25

Pharmacology for MAXZIDE-25

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms IncMAXZIDE-25hydrochlorothiazide; triamtereneTABLET;ORAL019129-003May 13, 1988ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
US Army
Deloitte
Julphar
Teva
AstraZeneca
Cerilliant
Fuji
Farmers Insurance
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot